FDA OTC IBUPROFEN APPROVAL ON ASSURANCE FROM WHITEHALL AND BRISTOL-MYERS FOR HYPERSENSITIVITY WARNING EXCEEDED AGENCY AUTHORITY, McNEIL SAYS IN SUIT

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".